IL6 and diabetes mellitus: Moreover, gut barrier dysregulations and pathologies promote the production of proinflammatory cytokines (IL-6 and TNF-α), which in turn trigger subclinical inflammation and insulin resistance, shedding light again on the inflammation loop between CRC and diabetes [3].